Back to Newsroom

Catalyst Pharmaceuticals Appoints David J. Caponera as Vice President Patient Advocacy and Reimbursement

CORAL GABLES, Fla., Oct. 28, 2014 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) (Catalyst Pharmaceuticals), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, announced the appointment of David J. Caponera to the newly created position, vice president, patient advocacy and reimbursement, effective immediately. Mr. Caponera will report to David D. Muth, executive vice president, corporate development.

Click here to read more